23andMe ’s Pharmacogenetic Test Approved by FDA

The FDA has just approved 23andMe’s Personal Genomic Service (PGS) Pharmacogenetic Reports. This marks the first direct-to-consumer test for pharmacogenetics of enzyme variants that may affect the way patients break down medications. Consumers ...
Source: Medgadget - Category: Medical Devices Authors: Tags: Diagnostics Genetics News Source Type: blogs